Why Genetic Testing Should Be Standard in Prostate Cancer

Labcorp, Rebecca Previs, Sarah Young, genetic counselor, genetic testing, prostate cancer, urologic oncology, germline, somatic, PARP inhibitors, digital

Hear why universal genetic testing matters in prostate cancer — plus, how it can improve treatment, equity, and outcomes for patients everywhere.

May 18^th • 19 mins listen

Breaking Down Checkpoint Inhibitors

ONS member Virginia Bayer, BSN, RN, CCRP, research nurse supervisor at MD Anderson Cancer Center, joins ONS’s Barbara Lubejko, MS, RN, to discuss checkpoint inhibitors, their impact on patient care, what oncology nurses need to know about immunotherapies, and much more.

Mar 14^th • 51 mins listen

New Machine Learning Framework Uses EHR Data to Assess ICI Effectiveness, Toxicity

Drs. Shaalan Beg and Travis Osterman discuss a machine learning model, recently featured in JCO Clinical Cancer Informatics, that uses electronic health record data to accurately predict the effectiveness and toxicity of treatment with immune checkpoint inhibitors. The new AI model can be use…

Mar 21^st • 16 mins listen